###begin article-title 0
Cannabinoid Type 1 Receptor Blockade Promotes Mitochondrial Biogenesis Through Endothelial Nitric Oxide Synthase Expression in White Adipocytes
###end article-title 0
###begin p 1
###xml 34 54 34 54 <email xmlns:xlink="http://www.w3.org/1999/xlink">enzo.nisoli@unimi.it</email>
Corresponding author Enzo Nisoli, enzo.nisoli@unimi.it
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
OBJECTIVE-Cannabinoid type 1 (CB1) receptor blockade decreases body weight and adiposity in obese subjects; however, the underlying mechanism is not yet fully understood. Nitric oxide (NO) produced by endothelial NO synthase (eNOS) induces mitochondrial biogenesis and function in adipocytes. This study was undertaken to test whether CB1 receptor blockade increases the espression of eNOS and mitochondrial biogenesis in white adipocytes.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 363 366 363 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 172 177 <span type="species:ncbi:10090">mouse</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
RESEARCH DESIGN AND METHODS-We examined the effects on eNOS and mitochondrial biogenesis of selective pharmacological blockade of CB1 receptors by SR141716 (rimonabant) in mouse primary white adipocytes. We also examined eNOS expression and mitochondrial biogenesis in white adipose tissue (WAT) and isolated mature white adipocytes of CB1 receptor-deficient (CB1-/-) and chronically SR141716-treated mice on either a standard or high-fat diet.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 628 632 <span type="species:ncbi:10090">mice</span>
RESULTS-SR141716 treatment increased eNOS expression in cultured white adipocytes. Moreover, SR141716 increased mitochondrial DNA amount, mRNA levels of genes involved in mitochondrial biogenesis, and mitochondrial mass and function through eNOS induction, as demonstrated by reversal of SR141716 effects by small interfering RNA-mediated decrease in eNOS. While high-fat diet-fed wild-type mice showed reduced eNOS expression and mitochondrial biogenesis in WAT and isolated mature white adipocytes, genetic CB1 receptor deletion or chronic treatment with SR141716 restored these parameters to the levels observed in wild-type mice on the standard diet, an effect linked to the prevention of adiposity and body weight increase.
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
CONCLUSIONS-CB1 receptor blockade increases mitochondrial biogenesis in white adipocytes by inducing the expression of eNOS. This is linked to the prevention of high-fat diet-induced fat accumulation, without concomitant changes in food intake.
###end p 6
###begin p 7
Published ahead of print at  on 13 May 2008.
###end p 7
###begin p 8
U.P. has been a consultant for, has served on an advisory board for, and has received honoraria from sanofi-aventis. R.P. has received honoraria from sanofi-aventis.
###end p 8
###begin p 9
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 9
###begin p 10
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 234 235 234 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 523 524 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 777 778 765 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 779 780 767 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 870 873 858 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 937 938 925 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 939 940 927 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 860 864 <span type="species:ncbi:10090">mice</span>
Adipose tissue is not merely an energy store but rather an endocrine organ playing an important role in fuel metabolism (1,2). Recent studies have demonstrated that mitochondrial biogenesis increases during adipocyte differentiation (3), and this is presumably due at least in part to the presence of the endothelial nitric oxide (NO) synthase (eNOS). In fact, eNOS protein is not expressed in either undifferentiated 3T3-L1 cells or preadipocytes, whereas its expression markedly increases with adipocyte differentiation (4). It is noteworthy that NO increases mitochondrial biogenesis in white adipocytes via cyclic guanosine monophosphate (cGMP)-dependent pathways, including peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) gene expression (5,6). Consistently, mitochondrial biogenesis is reduced in fat of eNOS-null mutant mice (eNOS-/-), with decreased energy expenditure and increased body weight (5,6). This suggests that the eNOS-dependent mitochondrial biogenesis is relevant to adipocyte maturation and fuel metabolism.
###end p 10
###begin p 11
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 607 610 607 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
Cannabinoid type 1 (CB1) receptors participate in the physiological modulation of many central and peripheral functions related to the control of energy metabolism (7). They are the most abundant G protein-coupled receptors expressed in the brain, where CB1 receptor activation promotes feeding and modulates the rewarding properties of food (7-9). CB1 receptors also control metabolic functions by acting on peripheral organs, including white adipose tissue (WAT) (7-9). Notably, in adipocytes, CB1 receptor expression increases with cell differentiation (10,11). Moreover, CB1 receptor-deficient mice (CB1-/-) are lean (12) and resistant to a high-fat diet (13). Similarly, the selective CB1 receptor antagonist SR141716 (rimonabant) persistently reduces body weight during the treatment of obese animals, although food intake renormalizes after an initial 1- to 2-week weight reduction (14,15), suggesting that CB1 receptor blockade stimulates fat metabolism, leading to a decreased fat content.
###end p 11
###begin p 12
We now demonstrate a prominent role for the CB1 receptors to modulate eNOS gene expression and mitochondrial biogenesis in white adipocytes. Collectively, these data suggest that targeting the endocannabinoid system improves mitochondrial function, implying a novel, unrecognized mechanism of action for the antiobesity drug rimonabant.
###end p 12
###begin title 13
RESEARCH DESIGN AND METHODS
###end title 13
###begin title 14
Cell culture.
###end title 14
###begin p 15
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
White fat precursor cells were enzymatically isolated from epididymal WAT of wild-type C57BL/6J mice and cultured as described (16). SR141716 [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide, hydrochloride, contract no. N01-MH-32005 WA 08928.019, National Institute of Mental Health no. S-705, Chemical Synthesis and Drug Supply Program, National Institute of Mental Health; RTI)] stock solutions (50 mmol/l in DMSO) were diluted in the culture medium to the required final concentrations containing up to 0.02% DMSO. At days 3-4 from seeding, cells were exposed to the culture medium containing SR141716 (0.1-10 mumol/l) for 72 h or different periods of time when specified. The medium was discarded, the wells were washed twice with 2 ml ice-cold PBS (Sigma-Aldrich), and the cells were harvested as reported below for the different assays.
###end p 15
###begin title 16
eNOS small interfering RNA.
###end title 16
###begin p 17
###xml 151 160 151 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">siCONTROL</italic>
###xml 358 361 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GLO</italic>
White adipocytes were transfected at days 3-4 after seeding with 100 nmol/l eNOS small interfering RNA (siRNA) SMARTpool (Dharmacon, Lafayette, CO) or siCONTROL nontargeting siRNA using Dharmafect 3 transfection reagent. Cells were treated for 72 h with 1 mumol/l SR141716, and RNA and protein were harvested. Efficacy of transfection was determined using siGLO-RISC-free nontargeting siRNA and estimation of siRNA uptake by fluorescence detection (absorbance/emission 557/570 nm).
###end p 17
###begin title 18
Animals and treatments.
###end title 18
###begin p 19
###xml 153 156 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r17">17</xref>
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 643 644 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 986 987 986 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 245 250 <span type="species:ncbi:10090">mouse</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
Animals were treated according to protocols approved by Milan and Bologna University institutional animal care and use committee. Eight-week-old male CB1-/- mice (17) and their wild-type littermates (n = 10 per group) were fed either a standard mouse diet (8% kcal fat, 19% kcal protein, and 73% kcal carbohydrate) or a high-fat diet (D12492, 60% kcal fat, 20% kcal protein, and 20% kcal carbohydrate; Research Diets, New Brunswick, NJ) for 12 weeks. Moreover, 4-week-old male C57BL/6J mice (Harlan Nossan) were fed either a standard diet or high-fat diet for 6 weeks before treatments. While fed on the standard or high-fat diet, these mice (n = 10 per group) were further treated with either vehicle or SR141716 (at 10 mg/kg orally in distilled water with 0.1% Tween 80) for 11 weeks. Body weight and food intake were recorded weekly. Adiposity (wet weight of visceral and subcutaneous fat), cumulative food intake (for the time of the experiment), and feed efficiency were measured (5). On the day of the experiments, animals were killed by cervical dislocation and epididymal WAT was immediately isolated, frozen in liquid nitrogen, and stored at -80degreesC before processing for mRNA, protein, and mtDNA analysis or citrate synthase and AMP-activated protein kinase (AMPK) activity.
###end p 19
###begin title 20
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
Isolation of mouse mature adipocytes.
###end title 20
###begin p 21
###xml 17 20 17 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 64 65 64 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 183 184 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 220 224 <span type="species:ncbi:10090">Mice</span>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
Wild-type and CB1-/- mice were fed a standard or high-fat diet (n = 6 per group), and wild-type mice either on standard or high-fat diet were treated with either vehicle or SR141716 (n = 6 per group) as described above. Mice were killed and epididymal WAT excised. Fat pads from two mice were pooled, and mature adipocytes were acutely isolated in Hank's balanced salt solution containing 4% BSA and 1.5 mg/ml collagenase (Calbiochem) as described (18).
###end p 21
###begin title 22
RNA analysis.
###end title 22
###begin p 23
###xml 352 353 352 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 542 543 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 543 544 543 544 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
###xml 605 606 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 606 607 599 600 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
###xml 651 666 644 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;(&#916;&#916;CT)</sup>
###xml 702 703 675 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 703 704 676 677 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
###xml 779 780 748 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 780 781 749 750 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
###xml 744 748 <span type="species:ncbi:10090">mice</span>
###xml 797 801 <span type="species:ncbi:10090">mice</span>
RNA was isolated from tissue or cells using the RNeasy Lipid Tissue Mini Kit (Qiagen). cDNA was synthesized using iScript cDNA Synthesis Kit (Bio-Rad Laboratories). Primers were designed using Beacon Designer 2.6 software from Premier Biosoft International. Triplicate PCR were carried out with the intercalating dye SybrGreen as previously described (5,16). PCR cycles were programmed on an iCycler iQ Real-Time PCR detection system (Bio-Rad Laboratories). The cycle number at which the various transcripts were detectable (threshold cycle [CT]) was compared with that of beta-actin, referred to as DeltaCT. The gene relative level was expressed as 2-(DeltaDeltaCT), in which DeltaDeltaCT equals DeltaCT of either the knockout or drug-treated mice (or treated cells) minus DeltaCT of the control mice (or untreated cells).
###end p 23
###begin title 24
Immunoblot analysis.
###end title 24
###begin p 25
###xml 267 268 267 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 997 1008 <span type="species:ncbi:3704">horseradish</span>
###xml 1036 1042 <span type="species:ncbi:9986">rabbit</span>
###xml 1051 1056 <span type="species:ncbi:10090">mouse</span>
Protein extracts were obtained by harvesting cultured adipocytes in M-PER Mammalian Protein Extraction Reagent or homogenizing WAT tissue in T-PER Tissue Protein Extraction Reagent (both from Pierce), as indicated by the manufacturer, in the presence of 1 mmol/l NaVO4, 10 mmol/l NaF, and a cocktail of protease inhibitors (Sigma-Aldrich). Protein content was determined by the bicinchoninic acid protein assay (Pierce), and 50 mug of proteins were run on SDS-PAGE under reducing conditions. The separated proteins were then electrophoretically transferred to a nitrocellulose membrane (Pierce). Proteins of interest were revealed with specific antibodies: anti-eNOS (Transduction Labs), anti-cytochrome c oxidase (COX IV) (Molecular Probes), anti-cytochrome c (BD Bioscience), each one at 1:500 dilution; anti-phospho-AMPKalpha (Thr172) and anti-AMPKalpha (both at 1:1,000 dilution; Cell Signaling Technology); and anti-beta-actin (1:10,000; Sigma-Aldrich). The immunostaining was detected using horseradish peroxidase-conjugated anti-rabbit or anti-mouse immunoglobulin for 1 h at room temperature. After the visualization of phospho-AMPKalpha, filters were stripped with the Re-Blot Western blot recycling kit (Chemicon International) and further used for the visualization of total AMPKalpha. Bands were revealed by the SuperSignal Substrate (Pierce) and quantitated by densitometry using a Quick Image densitometer (Canberra Packard) and a Phoretix 1D, version 3.0, software image analyser.
###end p 25
###begin title 26
Fluorescence-activated cell sorting analysis.
###end title 26
###begin p 27
###xml 97 98 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
White adipocytes were treated or not with 1 mumol/l SR141716 for 72 h. Cells (approximately1 x 106 per sample) were harvested by trypsinization, fixed with 4% paraformadehyde in PBS for 10 min, and incubated 1 h at room temperature in a permeabilization buffer containing 1% BSA, 0.1% saponin, and either anti-COX IV or anti-cytochrome c antibody. After incubation with labeled secondary antibody, the fluorescence was analyzed by flow cytometry (FACScan; Becton Dickinson, Sunnyvale, CA) and Cell Quest software (Becton Dickinson). Data are expressed as relative fluorescence intensity of the mean fluorescent signal versus unstained samples.
###end p 27
###begin title 28
Mitochondrial DNA.
###end title 28
###begin p 29
###xml 50 52 50 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 663 666 663 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
Mitochondria were isolated from tissue and cells (19). The mitochondrial DNA (mtDNA) was extracted and analyzed as described (5,16). Briefly, an aliquot of mtDNA was loaded on ethidium bromide-stained agarose gel (1.2%) and quantified using the QuickImage densitometer (Packard). To determine mtDNA levels, the signal intensities were normalized to cell numbers in experiments on cultured cells or to protein content in experiments using tissues from wild-type and knockout mice. Alternatively, mtDNA copy number was measured by means of quantitative PCR from the cytochrome C oxidase II mtDNA gene compared with the uncoupled protein-2 nuclear gene in WAT of CB1-/- and wild-type mice as described (20).
###end p 29
###begin title 30
Oxygen consumption.
###end title 30
###begin p 31
###xml 69 70 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 165 166 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 367 368 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 369 371 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
White adipocytes were harvested by trypsinization, centrifuged at 500g for 5 min at 4degreesC, and resuspended in Hank's balanced salt solution. Cell samples (4 x 106/ml) were analyzed at 37degreesC in a gas-tight vessel equipped with a Clark-type oxygen electrode (Rank Brothers) connected to a chart recorder. Cellular oxygen consumption was measured as described (5,16). The oxygen electrode was calibrated, assuming the concentration of oxygen in the incubation medium at 37degreesC to be 200 mumol/l. Protein content in both cell and tissue samples was determined by the bicinchoninic acid protein assay (Pierce).
###end p 31
###begin title 32
ATP levels.
###end title 32
###begin p 33
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 351 352 345 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
The whole amount of ATP in cells was measured by using the ATP determination kit from Molecular Probes. Cells were harvested by trypsinization and centrifuged at 500g for 5 min at 4degreesC. ATP was extracted by incubating cell pellets with 1% trichloroacetic acid per 4 mmol/l EDTA solution for 10 min on ice. Cell extracts were centrifuged at 12,000g for 10 min at 4degreesC and used for ATP determination as indicated by the manufacturer.
###end p 33
###begin title 34
Mitochondrial mass.
###end title 34
###begin p 35
White adipocytes seeded onto glass coverslips were incubated with medium containing 200 nmol/l Mitotracker red 580 (Invitrogen). After incubation for 30 min at 37degreesC, coverslips were rinsed two times with medium and two times with PBS and fixed at room temperature for 10 min in 4% paraformaldehyde in PBS. Coverslips were mounted onto glass slides and were then observed with a Bio-Rad confocal microscope MRC1024.
###end p 35
###begin title 36
Citrate synthase activity.
###end title 36
###begin p 37
###xml 114 116 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
The activity was measured spectrophotometrically at 412 nm at 30degreesC in either tissue or whole-cell extracts (21). Tissue or cell homogenates were added to buffer containing 0.1 mmol/l 5,5-dithio-bis-(2-nitrobenzoic) acid, 0.5 mmol/l oxaloacetate, 50 mumol/l EDTA, 0.31 mmol/l acetyl CoA, 5 mmol/l triethanolamine hydrochloride, and 0.1 mol/l Tris-HCl, pH 8.1. Citrate synthase activity was expressed as nanomoles citrate produced per minute per milligram of protein.
###end p 37
###begin title 38
AMPK assay.
###end title 38
###begin p 39
###xml 50 52 50 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 86 87 86 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 186 189 186 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 367 369 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 445 447 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 591 593 580 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
Adipocytes were scraped in ice-cold lysis buffer (22) in the presence of 1 mmol/l NaVO4, 10 mmol/l NaF, and protease inhibitors (Sigma-Aldrich). Epididymal fat pads from wild-type or CB1-/- mice were homogenized in ice-cold lysis buffer. AMPK activity was determined on protein samples immunoprecipitated with anti-AMPKalpha (Cell Signaling Technology) as described (22). The immunocomplexes were collected and washed with AMPK reaction buffer (22). AMPK immunoprecipitates were incubated with 20 mul of AMPK reaction buffer, 5 mul of SAMS substrate peptide (1 mmol/l), and 2 muCi of [gamma-32P]ATP (MP Biomedicals) for 30 min at 37degreesC. At the end of the incubation, an aliquot was removed and spotted onto Whatman P81 paper. The P81 paper was washed three times with 0.75% (vol/vol) phosphoric acid and once with acetone, and radioactivity was determined by scintillation counting.
###end p 39
###begin title 40
Statistical methods.
###end title 40
###begin p 41
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Raw data from each experiment were analyzed using either an ANOVA with Newman-Keuls' multiple comparison post hoc test or t test.
###end p 41
###begin title 42
RESULTS
###end title 42
###begin title 43
CB1 receptor antagonist increases eNOS expression and mitochondrial biogenesis in white adipocytes.
###end title 43
###begin p 44
###xml 154 155 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 148 155 148 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 183 184 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 177 184 177 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
CB1 receptor antagonist SR141716 affects eNOS expression in mouse white adipocytes in culture. In fact, the drug significantly increased eNOS mRNA (Fig. 1A) and protein levels (Fig. 1B) in a dose-dependent manner (0.1-10 mumol/l for 72 h).
###end p 44
###begin p 45
###xml 314 316 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 317 319 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r24">24</xref>
###xml 400 401 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 394 401 389 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A</italic></xref>
###xml 595 596 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 589 596 584 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>B</italic></xref>
###xml 786 787 771 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 805 806 790 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 927 928 912 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 933 934 918 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 921 934 906 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>C</italic> and <italic>D</italic></xref>
###xml 1096 1097 1077 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1115 1116 1096 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1320 1321 1301 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1314 1321 1295 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>E</italic></xref>
The effect of SR141716 was further tested on several markers of mitochondrial biogenesis. The amount of mtDNA (a marker of mitochondrial content) and the mRNA levels of PGC-1alpha, nuclear respiratory factor-1 (NRF-1), and mtDNA transcription factor A (Tfam) (three master regulators of mitochondrial biogenesis) (23,24) were higher in 1 mumol/l SR141716-treated than in vehicle-treated cells (Fig. 2A). Protein levels of COX IV and cytochrome c (two mitochondrial proteins involved in oxidative phosphorylation) were also increased by SR141716 treatment as assessed either by immunoblot (Fig. 2B) or by flow cytometry (mean fluorescence intensity +/- SE of SR141716- vs. vehicle-treated cells: 20.1 +/- 3.4 vs. 9.6 +/- 2.3 for COX IV and 15.6 +/- 3.2 vs. 9.9 +/- 1.9 for cytochrome c; n = 3 experiments; P < 0.001). Both activity of citrate synthase and oxygen consumption were markedly increased by SR141716 treatment (Fig. 2C and D). Consistently, the ATP levels in the SR141716-treated cells were significantly higher than those in the vehicle-treated cells (1.73 +/- 0.19 vs. 1.34 +/- 0.16; n = 3 experiments, P < 0.05). Finally, white adipocytes treated with SR141716 showed a significant increase of Mitotracker red signal, indicating the increase of mitochondrial mass compared with vehicle-treated cells (Fig. 2E). Altogether, these findings demonstrate that pharmacological blockade of the CB1 receptor increases eNOS expression and mitochondrial biogenesis and function in white adipocytes.
###end p 45
###begin title 46
SR141716 effects on mitochondrial biogenesis are eNOS dependent.
###end title 46
###begin p 47
###xml 449 450 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 455 456 455 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 443 456 443 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic> and <italic>D</italic></xref>
###xml 603 606 603 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;E</italic>
###xml 597 606 597 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A&#8211;E</italic></xref>
###xml 832 835 831 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;E</italic>
###xml 826 835 825 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f2" ref-type="fig">Fig. 2<italic>A&#8211;E</italic></xref>
Coregulation of eNOS expression and mitochondrial biogenesis in the SR141716-treated adipocytes suggests that these processes might be mechanistically linked. To assess whether eNOS expression is relevant in the drug-induced mitochondrial biogenesis, white adipocytes were transfected with siRNA against eNOS or a scrambled RNA sequence. siRNA against eNOS reduced basal eNOS mRNA and protein levels by 82 and 85%, respectively, in WAT cells (Fig. 1C and D), with a moderate, but statistically significant, decrease of all measured parameters of mitochondrial biogenesis in vehicle-treated cells (Fig. 2A-E). Importantly, however, siRNA against eNOS strongly decreased mitochondrial biogenesis induced by 1 mumol/l SR141716 treatment, indicating that the effect of SR141716 depends, at least in part, on the presence of eNOS (Fig. 2A-E).
###end p 47
###begin title 48
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Mitochondrial biogenesis is increased in WAT of CB1-/- mice.
###end title 48
###begin p 49
###xml 222 225 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 427 430 427 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A&#8211;D</italic>
###xml 421 430 421 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A&#8211;D</italic></xref>
###xml 463 466 463 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 574 575 574 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 568 575 568 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 594 597 594 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 665 666 661 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 659 666 655 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 701 702 697 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 695 702 691 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 736 737 732 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 730 737 726 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 787 788 783 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 781 788 777 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f3" ref-type="fig">Fig. 3<italic>D</italic></xref>
###xml 1088 1091 1084 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 415 419 <span type="species:ncbi:10090">mice</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
To assess whether the CB1 receptor blockade increases mitochondrial biogenesis in WAT in vivo, we examined the eNOS expression and markers of mitochondrial biogenesis in epididymal fat pads derived from 8-week-old male CB1-/- mice and their wild-type littermates either on a standard or high-fat diet for 12 weeks. As expected (16), a high-fat diet reduced eNOS expression and mitochondrial biogenesis in wild-type mice (Fig. 3A-D). eNOS mRNA levels in WAT of CB1-/- mice were significantly higher than those of wild-type mice on both the standard and high-fat diets (Fig. 3A). Furthermore, CB1-/- mice displayed increased mRNA levels of PGC-1alpha and Tfam (Fig. 3A), COX IV, and cytochrome c (Fig. 3C); increased mtDNA amounts (Fig. 3B); and increased citrate synthase activity (Fig. 3D) compared with wild-type littermates. These increments were evident in animals either on standard or high-fat diets. To confirm that the mitochondrial biogenesis induced by CB1 gene deletion occurs in white adipocytes in vivo, mature white adipocytes were isolated from the epididymal fat pad of CB1-/- and wild-type littermates after standard or high-fat diets. Although we do not rule out that other cell types present in whole WAT (i.e., endothelial cells, macrophages, or others) may be involved, we found that CB1 gene deletion increases eNOS expression and mitochondrial biogenesis and function in white adipocytes (online appendix Fig. 1 [available at ]).
###end p 49
###begin p 50
###xml 25 27 25 27 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 313 316 313 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 447 448 447 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 453 454 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 583 584 583 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 599 602 599 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 780 781 780 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
As previously described (12), CB1-/- mice on the standard diet had a lower body weight and adiposity (online appendix Fig. 2A) than wild-type controls, having showed a significantly reduced body weight compared with wild-type mice throughout the whole period of observation (data not shown). Most importantly, CB1-/- mice maintained a leaner phenotype under the high-fat diet as evidenced by lower body weight and adiposity (online appendix Fig. 2A and B) (13). Cumulative food intake was comparable between the two groups of mice on standard or high-fat diet (online appendix Fig. 2C), although CB1-/- mice showed a smaller feed efficiency (weight gain/food intake, an indirect measurement of increased energy expenditure) than their wild-type littermates (online appendix Fig. 2D).
###end p 50
###begin title 51
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Defective mitochondrial biogenesis is restored in WAT of high-fat diet-fed SR141716-treated mice.
###end title 51
###begin p 52
###xml 316 318 316 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 322 324 322 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 358 360 358 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 399 402 399 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 745 751 745 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
###xml 1136 1142 1136 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f4" ref-type="fig">Fig. 4</xref>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
###xml 598 602 <span type="species:ncbi:10090">mice</span>
###xml 688 692 <span type="species:ncbi:10090">mice</span>
###xml 739 743 <span type="species:ncbi:10090">mice</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
###xml 1109 1113 <span type="species:ncbi:10090">mice</span>
###xml 1240 1244 <span type="species:ncbi:10090">mice</span>
CB1 receptor effects on mitochondrial biogenesis were further confirmed in vivo by a long-term treatment with the CB1 receptor antagonist. Four-week-old male mice were put on either standard or high-fat diet. Starting at week 10, standard diet-and high-fat diet-fed mice were treated either with SR141716 (10 mg . kg-1 day-1 orally) or vehicle for 11 weeks (13-15). Consistent with the data from CB1-/- mice, eNOS mRNA and protein levels and mitochondrial biogenesis were significantly higher in WAT of the SR141716-treated high-fat diet-fed mice than in those of vehicle-treated high-fat diet-fed mice, although as expected (16), they were lower in the vehicle-treated high-fat diet-fed mice than in the vehicle-treated standard diet-fed mice (Fig. 4). These results suggest that SR141716 treatment amends the high-fat diet-induced impairment of the NO generating system, restoring the mitochondrial function at levels observed in wild-type mice on a standard diet. Treatment with SR141716 induced only a slight, but not statistically significant, increase of eNOS expression and mitochondrial biogenesis in mice on the standard diet (Fig. 4). Superimposable results were obtained in isolated mature white adipocytes from SR141716-treated mice (online appendix Fig. 3).
###end p 52
###begin p 53
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 192 193 192 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 475 476 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 647 648 647 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 653 654 653 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
Interestingly, the mean body weight and adiposity of the SR141716-treated mice were markedly lower compared with that of vehicle-treated mice on the high-fat diet (online appendix Fig. 4A and B). Cumulative food intake was comparable between the drug- and vehicle-treated animals on a high-fat diet (online appendix Fig. 4C), whereas SR141716-treated mice showed a reduced feed efficiency compared with their vehicle-treated high-fat diet-fed controls (online appendix Fig. 4D). Only slight, but not statistically significant, decreases in body weight and adiposity were seen in the SR141716-treated mice on a standard diet (online appendix Fig. 4A and B).
###end p 53
###begin title 54
CB1 receptor blockade stimulates AMPK phosphorylation and activity.
###end title 54
###begin p 55
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 319 320 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 313 320 312 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 371 372 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 365 372 364 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 416 418 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 677 678 676 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 683 684 682 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 671 684 670 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>C</italic> and <italic>D</italic></xref>
###xml 720 721 719 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 714 721 713 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 743 744 742 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 737 744 736 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f5" ref-type="fig">Fig. 5<italic>D</italic></xref>
###xml 797 800 796 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 801 805 <span type="species:ncbi:10090">mice</span>
###xml 864 868 <span type="species:ncbi:10090">mice</span>
The AMPK cascade has been described to activate eNOS and NO production (25). Thus, AMPK might be involved in the effect of CB1 receptor blockade on eNOS-mediated mitochondrial biogenesis. In fact, treatment of cultured white adipocytes with 1 mumol/l SR141716 induced a rapid and persistent AMPK phosphorylation (Fig. 5A) and significantly increased AMPK activity (Fig. 5B). Moreover, in line with previous reports (26), we found that AMPK activity was lower in the WAT of wild-type mice fed a high-fat diet compared with those fed a standard diet. Noticeably, while CB1 receptor deletion did not affect AMPK phosphorylation or activity in WAT of standard diet-fed mice (Fig. 5C and D), both AMPK phosphorylation (Fig. 5C) and activity (Fig. 5D) were normalized in the WAT of high-fat diet-fed CB1-/- mice, up to the levels measured in wild-type standard diet-fed mice.
###end p 55
###begin p 56
Taken together, these findings demonstrate that the CB1 receptor blockade in vivo concomitantly activates AMPK cascade and upregulates eNOS expression and mitochondrial biogenesis, which are impaired by a high-fat diet in WAT, and these processes may be involved in the control of adiposity and body weight of animals on a high-fat diet.
###end p 56
###begin title 57
DISCUSSION
###end title 57
###begin p 58
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r14">14</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 480 482 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 483 485 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 1076 1078 1068 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r30">30</xref>
###xml 1150 1152 1142 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r31">31</xref>
###xml 1153 1155 1145 1147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r32">32</xref>
###xml 503 508 <span type="species:ncbi:9606">human</span>
The present study demonstrates that genetic and pharmacological blockade of the cannabinoid CB1 receptor increases mitochondrial biogenesis in white adipocytes. Treatment of adipocytes with SR141716, a selective antagonist of CB1 receptors (14,15,27), increases mitochondrial biogenesis genes, including PGC-1alpha and Tfam. This possibly implies that SR141716 is antagonizing an endocannabinoid tone present in cultured fat cells. It has been recently reported by us and others (28,29) that rodent and human adipocytes produce and release endocannabinoids, including 2-arachidonoylglycerol, anandamide, and other cannabimimetic compounds. Thus, our results suggest that SR141716 increases mitochondrial biogenesis by antagonizing the endocannabinoids produced in cell culture. In turn, this strongly implies that the CB1 receptor agonists might downregulate the eNOS-dependent mitochondrial biogenesis in white adipocytes. Consistently, cannabinoids, including Delta(9)-tetrahydrocannabinol, inhibit the respiratory enzyme system in brain, liver, skeletal muscle, and heart (30) and, consequently, reduce the rates of oxygen consumption in rodents (31,32).
###end p 58
###begin p 59
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r33">33</xref>
We have recently found that eNOS-dependent NO production induces mitochondrial biogenesis in different cell types, including white adipocytes, by cGMP-dependent pathways and that the newly synthesized mitochondria are functionally active, ensuing high oxygen consumption and ATP production (5,6,33). This suggests that the SR141716-dependent increase in eNOS expression is mechanistically linked to the mitochondrial biogenesis induced by the CB1 receptor blockade. This was confirmed by the observation that gene silencing of eNOS by RNAi markedly impairs the SR141716 stimulatory effects on mitochondrial biogenesis and function in cultured adipose cells.
###end p 59
###begin p 60
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r34">34</xref>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r35">35</xref>
###xml 611 613 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
###xml 812 818 <span type="species:ncbi:9606">humans</span>
###xml 971 975 <span type="species:ncbi:10090">mice</span>
We observed that genetic CB1 receptor blockade in vivo increases eNOS expression and mitochondrial biogenesis both in whole WAT and isolated mature white adipocytes, and this is accompanied by prevention of high-fat diet-induced fat accumulation. Most importantly, the pharmacological CB1 receptor blockade fully counteracts the downregulation of eNOS-dependent mitochondrial biogenesis due to a high-fat diet in mice. This might indicate a novel, previously unrecognized mechanism of action of SR141716 as an antiobesity drug. Not only would it transiently suppress food intake (34,35) and reduce lipogenesis (12), but it also would increase the oxidative metabolism in white adipocytes by counteracting the inhibitory effects of endocannabinoids, whose levels are increased in fat tissues of obese rodents and humans (28). Thus, we propose that the overactivity of endocannabinoids might contribute to downregulate mitochondrial biogenesis in white adipocytes of obese mice and that the blockade of adipose CB1 receptor might revert this process, thus preventing the high-fat diet-induced increase in adiposity and body weight gain.
###end p 60
###begin p 61
###xml 448 451 448 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 840 842 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r37">37</xref>
###xml 928 930 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r36">36</xref>
###xml 931 933 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r38">38</xref>
###xml 983 985 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r39">39</xref>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
There is an open question regarding the mechanisms that link CB1 receptor blockade to the eNOS expression. Furthermore, it remains to be clarified how the recovery of mitochondrial biogenesis and function in WAT could counteract the development of obesity. We found that SR141716 enhances AMPK activity in cultured white adipocytes and that the WAT AMPK activity, which is reduced by a high-fat diet, is normalized in WAT from high-fat diet-fed CB1-/- mice to the levels measured in wild-type standard-diet-fed mice. Since AMPK is known to enhance NO production by activating eNOS (25), the AMPK cascade might operate upstream of the NO generating system, possibly contributing to the CB1 blockade-mediated mitochondrial biogenesis. Accordingly, induction of AMPK activity has been found to increase mitochondrial content in adipocytes (36,37). Thus, the enhanced beta-oxidation of free fatty acids elicited by AMPK activation (36,38) and by eNOS-dependent mitochondrial biogenesis (39) might functionally link SR141716 treatment to its antiobesity effects.
###end p 61
###begin p 62
###xml 156 159 156 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 429 430 429 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
The mechanisms that link eNOS-derived NO to the gene expression machinery involved in mitochondrial biogenesis also remain to be elucidated. Studies of eNOS-/- mice have demonstrated an obligatory role of eNOS in mitochondrial biogenesis (5,6). Noticeably, eNOS, NO, and its intracellular messenger cGMP are located in both the cytoplasm and the nucleus, and several transcription factors possess heme moieties that can bind NO (6), but further investigation is needed to understand whether eNOS-mediated responses involve the nuclear NO/cGMP.
###end p 62
###begin p 63
###xml 324 326 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r40">40</xref>
###xml 327 329 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r41">41</xref>
###xml 473 475 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 599 601 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r42">42</xref>
###xml 687 689 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 811 813 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r43">43</xref>
It is now widely accepted that obesity is causally linked to a chronic, low-grade inflammation of visceral adipose tissue, characterized by infiltrating macrophages, abnormal cytokine production, and activation of a network of inflammatory signaling pathways, including tumor necrosis factor-alpha and inducible NOS (iNOS) (40,41). It has been observed that upregulation of iNOS (which is induced in inflammatory conditions) often correlates with a downregulation of eNOS (16). Corroborating this, tumor necrosis factor-alpha increases iNOS expression in different cells and tissues, including fat (42) and inhibits eNOS expression, mitochondrial function, and energy production in WAT (16). Interestingly, SR141716 has been shown to reduce plasma tumor necrosis factor-alpha levels in inflammatory conditions (43). Thus, we can speculate that the anti-inflammatory effects of SR141716 could help counteracting the increase of iNOS expression and the reduction of eNOS expression and mitochondrial biogenesis in high-fat diet-induced obesity.
###end p 63
###begin p 64
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r44">44</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r45">45</xref>
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r46">46</xref>
Endogenous cannabinoids and CB1 agonists promote vasodilation and decrease blood pressure, particularly in rodent models of hypertension (44,45). A variety of putative mechanisms could explain these effects, including the increased production of vasodilator NO in vessels. Although we have not analyzed the possible effects of SR141716 on eNOS expression in the vasculature, a recent analysis of the impact of rimonabant on blood pressure in the pooled population from four large trials with similar design (the Rimonabant-In-Obesity Program) demonstrates that there is no effect of rimonabant on blood pressure beyond the modest reduction mediated by weight loss (46).
###end p 64
###begin p 65
###xml 311 315 <span type="species:ncbi:10090">mice</span>
In conclusion, our results demonstrate that mitochondrial biogenesis and function, which are impaired by a high-fat diet, are restored to normal levels in white adipocytes by the CB1 receptor antagonist SR141716, and this is accompanied by prevention of adiposity and body weight increase in high-fat-fed obese mice. In view of the present findings, targeting eNOS expression and mitochondrial biogenesis might offer therapeutic gains and simplify the drug approach to clinical situations as complex as obesity and related disorders.
###end p 65
###begin title 66
Supplementary Material
###end title 66
###begin title 67
Online-Only Appendix
###end title 67
###begin p 68
This work was supported by grants from the Ministero della Salute (to E.N. and M.O.C.); the Cofinanziamento 2005 Programmi di Ricerca Scientifica di Rilevante Interesse Nazionale from the Ministero dell'Istruzione, dell'Universita e della Ricerca (to E.N., MOC., and R.V.); the Diabesity EC-FP6 (contract no. LSHM-CT-2003-503041) (to U.P.); Fondazione Cassa di Risparmio, Bologna, Italy (to C.C., R.P., and U.P.); Avenir Program of Institut National de la Sante et de la Recherche Medicale, in partnership with the Fondation Bettencourt Schueller (to G.M.); and the European Federation Studies of Diabetis (EFSD/Sanofi-Aventis European Programme) (to G.M. and B.L.).
###end p 68
###begin p 69
We thank Clara De Palma for fluorescence-activated cell sorting analysis and Emilio Clementi for oxygen consumption measurements.
###end p 69
###begin title 70
REFERENCES
###end title 70
###begin p 71
###xml 112 113 112 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 498 499 495 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 519 520 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 595 596 592 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 833 834 827 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 839 840 833 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1072 1073 1066 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1095 1096 1089 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
The CB1 receptor antagonist SR141716 dose-dependently upregulates eNOS expression in cultured white adipocytes. A and B: eNOS mRNA and protein, analyzed by quantitative RT-PCR and immunoblotting, respectively, in vehicle-treated cells (0.02% DMSO) (Veh) or after exposure to different doses of SR141716 for 3 days. The cycle number at which the transcript was detectable was compared with that of beta-actin and expressed as relative expression versus values in vehicle-treated cells taken as 1.0 (n = 5 experiments) (*P < 0.05 vs. vehicle). eNOS protein was detected by immunoblot analysis (in B, one experiment representative of five reproducible ones). The numbers below the blots show the relative values from the densitometric analysis, relative to beta-actin levels, when control (vehicle) measurement is given a value of 1.0. C and D: eNOS expression in white adipocytes transfected with either 100 nmol/l scrambled control siRNA or eNOS siRNA and harvested 48 h later. eNOS mRNA and protein levels were measured by means of quantitative RT-PCR and immunoblotting (n = 3 experiments) (***P < 0.01 vs. transfection reagent-treated cells). All data represent means +/- SE.
###end p 71
###begin p 72
###xml 98 99 98 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 576 577 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 597 598 589 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 613 614 605 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 655 656 642 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 692 697 679 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Inset</italic>
###xml 900 901 887 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1259 1260 1243 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1306 1307 1290 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1366 1367 1350 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1387 1388 1371 1372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1432 1433 1411 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1502 1503 1479 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
SR141716 increases mitochondrial biogenesis through eNOS expression in cultured white adipocytes. A: PGC-1alpha, NRF-1, and Tfam mRNA levels were analyzed by means of quantitative RT-PCR with gene-specific oligonucleotide probes in white adipocytes treated either with vehicle (0.002% DMSO) (Veh) or 1 mumol/l SR141716 (SR) or 100 nmol/l eNOS siRNA (siRNA) either alone or combined. The cycle number at which the various transcripts were detectable was compared with that of beta-actin and expressed as relative expression versus values in vehicle-treated cells taken as 1.0 (n = 5 experiments). *P < 0.05 and ***P < 0.01 vs. vehicle-treated cells; daggerP < 0.05 vs. SR141716-treated cells. Inset: mtDNA (one experiment representative of five gels). The numbers show the relative amounts from the densitometric analysis when vehicle treatment measurements are given a value of 1.0; (M, DNA marker). B: COX IV and cytochrome c proteins were detected by immunoblot analysis (one experiment representative of five reproducible ones) in white adipocytes. The numbers below the blots show the relative values from the densitometric analysis, referred to beta-actin levels, when vehicle-treated cell measurement is given a value of 1.0. Citrate synthase activity (C) and oxygen consumption by white adipocytes (D). The values were normalized to the cell protein content (n = 3 experiments). *P < 0.05 vs. vehicle-treated cells and daggerP < 0.05 vs. SR141716-treated cells. All data represent means +/- SE. E: Mitochondrial mass in white fat cells visualized as mitotracker red signal by confocal microscopy. Images were acquired by using a x40 objective lens. (Please see  for a high-quality digital representation of this figure.)
###end p 72
###begin p 73
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 84 87 84 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 97 100 97 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 620 621 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 637 638 630 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 653 654 646 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 710 711 698 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 759 760 747 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 879 880 867 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 936 937 919 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 984 985 967 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1048 1049 1031 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1068 1069 1051 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1084 1085 1067 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1141 1142 1119 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 733 737 <span type="species:ncbi:10090">mice</span>
###xml 902 906 <span type="species:ncbi:10090">mice</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
###xml 1107 1111 <span type="species:ncbi:10090">mice</span>
###xml 1164 1168 <span type="species:ncbi:10090">mice</span>
Mitochondrial biogenesis is increased in WAT of CB1-/- mice. Eight-week-old male CB1-/- mice (CB1-/-) and their wild-type (WT) littermates (n = 8 per group) were fed either a standard diet (STD) or a high-fat diet (HFD) for 12 weeks. A and C: eNOS, PGC-1alpha, NRF-1, Tfam, COX IV, and cytochrome c mRNA levels, analyzed by means of quantitative RT-PCR with gene-specific oligonucleotide probes. The cycle number at which the transcript were detectable was compared with that of beta-actin as an internal control and expressed as relative expression versus values in wild-type animals on the standard diet taken as 1.0 (n = 8 animals) (*P < 0.05 and ***P < 0.01 vs. wild-type mice on a standard diet and daggerP < 0.05 vs. wild-type mice on a high-fat diet). B: mtDNA amount, analyzed by means of quantitative PCR and expressed as mtDNA copy number per nuclear DNA copy number. *P < 0.05 vs. wild-type mice on a standard diet and daggerP < 0.05 vs. wild-type mice on a high-fat diet. D: Citrate synthase activity normalized to WAT protein content (n = 3 experiments) *P < 0.05 and ***P < 0.01 vs. wild-type mice on a standard diet and daggerP < 0.05 vs. wild-type mice on a high-fat diet). All data represent means +/- SE.
###end p 73
###begin p 74
###xml 170 171 170 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 254 256 254 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 262 264 262 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 298 299 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 555 556 552 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 833 834 823 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 909 910 899 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1123 1124 1110 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1187 1188 1174 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1210 1211 1197 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1273 1274 1255 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1303 1304 1270 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
###xml 1060 1064 <span type="species:ncbi:10090">mice</span>
###xml 1239 1243 <span type="species:ncbi:10090">mice</span>
###xml 1332 1336 <span type="species:ncbi:10090">mice</span>
eNOS expression and mitochondrial biogenesis is increased in WAT of SR141716-treated mice. Four-week-old male mice were fed either standard (STD) or high-fat (HFD) diet (n = 20 per group) for 6 weeks and were then treated either with SR141716 (10 mg . kg-1 . day-1 orally) or vehicle for 11 weeks (n = 10 per group). A: eNOS mRNA and protein, analyzed by quantitative RT-PCR and immunoblotting, respectively. The bars show the relative values, referred to beta-actin levels, when vehicle-treated mice on standard diet measurement is given a value of 1.0. B: PGC-1alpha, NRF-1, and Tfam mRNA levels, analyzed by means of quantitative RT-PCR with gene-specific oligonucleotide probes. The bars show the relative values, referred to beta-actin levels, when vehicle-treated mice on the standard diet measurement is given a value of 1.0. C: mtDNA amount expressed as mtDNA copy number per nuclear DNA copy number. D: COX IV and cytochrome c protein levels, analyzed by means of immunoblot densitometric analysis, referred to beta-actin levels, when vehicle-treated mice on the standard diet measurement is given a value of 1.0. E: Citrate synthase activity normalized to WAT protein content (n = 3 experiments). ***P < 0.01 vs. vehicle-treated mice on a standard diet and daggerP < 0.05 or daggerdaggerdaggerP < 0.01 vs. vehicle-treated mice on a high-fat diet. All data represent means +/- SE.
###end p 74
###begin p 75
###xml 94 95 94 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 290 291 286 287 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 603 614 591 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Upper panel</italic>
###xml 671 682 659 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lower panel</italic>
###xml 862 863 850 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 878 879 866 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 914 915 902 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1069 1070 1053 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1105 1106 1089 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1125 1126 1109 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 1211 1214 1195 1198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1279 1290 1263 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Upper panel</italic>
###xml 1368 1379 1352 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lower panel</italic>
###xml 1441 1442 1425 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1498 1499 1477 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1546 1547 1525 1526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1629 1630 1608 1609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1650 1651 1629 1630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1707 1708 1681 1682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1215 1219 <span type="species:ncbi:10090">mice</span>
###xml 1362 1366 <span type="species:ncbi:10090">mice</span>
###xml 1464 1468 <span type="species:ncbi:10090">mice</span>
###xml 1521 1525 <span type="species:ncbi:10090">mice</span>
###xml 1673 1677 <span type="species:ncbi:10090">mice</span>
###xml 1730 1734 <span type="species:ncbi:10090">mice</span>
AMPK phosphorylation and activity is increased by CB1 receptor blockade in vitro and in vivo. A: Phosphorylation of AMPK was examined in cultured white adypocytes after exposure to vehicle (0.002% DMSO) (Veh) or 1 mumol/l SR141716 for different times. 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside (AICAR; 1 mmol/l) was used as a known inducer of AMPK phosphorylation. Western blot analyses were performed with an antibody specifically recognizing phospho-Thr172-AMPKalpha, then filters were stripped and reacted with an antibody recognizing both phosphorylated and unphosphorylated AMPKalpha. Upper panel: Blot images obtained from a representative experiment. Lower panel: Densitometric quantification of the blots from three independent cell preparations with phospho-AMPK normalized to total AMPK, when vehicle measurement is given a value of 100. *P < 0.05 and ***P < 0.01 vs. vehicle-treated cells. B: White adipocyte lysates were immunoprecipitated with AMPKalpha antibody, and the immunoprecipitates were then subjected to in vitro AMPK kinase assay. *P < 0.05 vs. vehicle-treated cells (n = 3 experiments). C: AMPK phosphorylation was measured in WAT protein samples from wild-type (WT) or CB1-/- mice fed either a standard diet (STD) or a high-fat diet (HFD). Upper panel: Representative immunoblots with triple protein samples from different mice. Lower panel: Bar graphs of densitometric quantification of the blots. ***P < 0.01 vs. wild-type mice on a standard diet and daggerP < 0.05 vs. wild-type mice on a high-fat diet. D: AMPK activity was measured as described above in epididymal WAT tissue lysates (n = 3 experiments) (*P < 0.05 vs. wild-type mice on a standard diet and daggerP < 0.05 vs. wild-type mice on a high-fat diet). All data represent means +/- SE.
###end p 75

